1-4 of 4
Ana C. De Oliveira
Close
Sort by
Journal Articles

Neurofilaments As Serum Biomarkers of Brentuximabvedotin-Induced Peripheral Neurotoxicity in CD30 + Lymphoma Patients: A Prospective Single-Center Study

Eva Domingo Domenech, Carla Marco, Eva Maria Gonzalez Barca, Cristina Muniesa, Patricia Lopez-Pereira, Ana C. De Oliveira, Carmen Aguilera, German Ferrer, Anna Maria Sureda Balari, Roser Velasco
Journal: Blood
Blood (2023) 142 (Supplement 1): 6186.
https://doi.org/10.1182/blood-2023-182348
Published: 2023
Journal Articles

Impact of Front-Line Treatment Interim PET/CT in Peripheral T-Cell Lymphoma Patients' Survival: Experience of a Single Center

Nicolo Rampi, Montserrat Cortes-Romera, Patricia Lopez-Pereira, Carolina Martinez-Ramos, Clara Montane Carbo, Carolina Esther Arevalo Leon, Ana C. De Oliveira, Eva Maria Gonzalez Barca, Anna Maria Sureda Balari, Eva Domingo Domenech
Journal: Blood
Blood (2023) 142 (Supplement 1): 6216.
https://doi.org/10.1182/blood-2023-186195
Published: 2023
Journal Articles

Health-Related Quality of Life (HRQoL) in Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL) Treated with Zanubrutinib+ Obinutuzumab Versus Obinutuzumab Monotherapy: The Rosewood Trial

Judith Trotman, Pier Luigi Zinzani, Yuqin Song, Richard Delarue, Gisoo Barnes, Pil Kim, Elena Ivanova, Boxiong Tang, Jiří Mayer, Ana C. De Oliveira, Sarit Assouline, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 1674.
https://doi.org/10.1182/blood-2023-181195
Published: 2023
Journal Articles

Comprehensive Geriatric Assessment in Diffuse Large B-Cell Lymphomas Patients Older Than 70 Years Old: Prospective Single-Center Experience

Nicolo Rampi, Maite Antonio, Eva Domingo Domenech, Patricia Lopez-Pereira, Ana C. De Oliveira, Carmen Aguilera, Anna Maria Sureda Balari, Eva Maria Gonzalez Barca
Journal: Blood
Blood (2023) 142 (Supplement 1): 6280.
https://doi.org/10.1182/blood-2023-190136
Published: 2023